CU
Highly rated in
7
conditions
Highly rated in
7
conditions
Check Dr. Connie S. Uzel's experience treating your condition:
About Dr. Connie S. Uzel

Connie Uzel is a Hematologist Oncology specialist and an Oncologist in Daphne, Alabama. Uzel has been practicing medicine for over 34 years and is highly rated in 7 conditions, according to our data. Her top areas of expertise are Smoldering Multiple Myeloma, Paget Disease of the Breast, Lung Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration. She is licensed to treat patients in Alabama. Uzel is currently accepting new patients.

Her participating in 11 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Connie S. Uzel it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Connie S. Uzel accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  UnitedHealthcare

Call to see if your plan is accepted.
Locations
29653 Anchor Cross Blvd, Daphne, AL 36526
Other Locations
1851 North Mckenzie Street, Ste 103, Foley, AL 36535
3719 Dauphin St, Mobile, AL 36608
Background & Education
Graduate Institution
University Of Arkansas College Of Medicine, 1988
Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in AL
Hospital Affiliations
South Baldwin Regional Medical Center
Springhill Medical Center
Thomas Hospital
Providence Hospital
Mobile Infirmary
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
View 10 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors